Stocks / NASDAQ / Proteostasis Therapeutics, Inc.

Proteostasis Therapeutics, Inc.

Our Opinion

Proteostasis Therapeutics is on the Cruelty Free Investing list for exploiting animals because the company does animal testing in development and commercialization of some of their therapeutics.

Supporting Evidence:

The company stated in the following press release that they conduct pre-clinical trials of their drugs on animals.

“This innovative initiative will combine Proteostasis’ unique discovery technology, novel targets and compounds that modulate key Proteostasis Network pathways with Elan’s long-standing strength in proprietary animal models, biology, medicinal chemistry and clinical development.” Read the following article

Company Description

Proteostasis Therapeutics, Inc., incorporated on December 13, 2006, is a biopharmaceutical company. The Company is engaged in the discovery and development of therapeutics that treat diseases caused by an imbalance in the proteostasis network, a set of pathways that control protein biosynthesis, folding, trafficking and clearance.
[Source: Reuters]

Company Website: